ACR Appropriateness Criteria(®) induction and adjuvant therapy for N2 non-small-cell lung cancer.
Willers H, Stinchcombe TE, Barriger RB, Chetty IJ, Ginsburg ME, Kestin LL, Kumar S, Loo BW Jr, Movsas B, Rimner A, Rosenzweig KE, Videtic GM, Chang JY; Expert Panel on Radiation Oncology-Lung:.
Willers H, et al. Among authors: kumar s.
Am J Clin Oncol. 2015 Apr;38(2):197-205. doi: 10.1097/COC.0000000000000154.
Am J Clin Oncol. 2015.
PMID: 25803563